Results 71 to 80 of about 13,589 (222)

Depot medroxyprogesterone acetate discontinuation after weight gain in 17-19 year old adolescent girls [PDF]

, 2002
Depot medroxyprogesterone acetate (DMPA) is a long acting progesterone only contraceptive agent. Side effects such as irregular bleeding patterns and weight gain are attributed to discontinuation.
Church, Donna Lea
core   +1 more source

Risk of Cancer With Hormone Replacement Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Hormone replacement therapy (HRT) remains the cornerstone of menopausal symptom management, effectively alleviating vasomotor symptoms and genitourinary syndrome, whilst mitigating long‐term risks such as osteoporosis. However, despite an increasing body of evidence on the relative safety of HRT, earlier studies that demonstrated an increased ...
Gabriella Yongue, Zachary Nash, Vikram Talaulikar, Shibani Nicum   +3 more
wiley   +1 more source

Hypercalcemia after the Discontinuation of Medroxyprogesterone Acetate

Internal Medicine, 2018
A 39-year-old woman was admitted to our hospital with symptoms of general fatigue, nausea, and vomiting that appeared three months after she stopped seven years of medroxyprogesterone acetate (MPA) medication for endometrial stromal sarcoma. Laboratory tests demonstrated moderate hypercalcemia.
Yuasa-Shibasaki, Erina, Ishii, Sumiyasu, Matsumoto, Shunichi, Tomaru, Takuya, Horiguchi, Kazuhiko, Osaki, Aya, Ozawa, Atsushi, Shibusawa, Nobuyuki, Satoh, Tetsurou, Yamada, Masanobu   +9 more
openaire   +3 more sources

Hormone Replacement Therapy for Menopausal Symptoms and the Risk of Cardiometabolic Disease: Current Evidence and Future Directions

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Background The transition through menopause is accompanied by a series of adverse metabolic changes which are associated with an increased risk of cardiometabolic disease, a major cause of mortality in women after midlife. Whilst the indication for menopausal hormone replacement therapy (HRT) is the control of menopausal symptoms ...
Jiawen Dong, Sarah Hillman, Sharon Dixon, Anupa Shah, Radha Venkatakrishnan, Jeremy W. Tomlinson   +5 more
wiley   +1 more source

Analytical Method Validation of High-Performance Liquid Chromatography and Stability-Indicating Study of Medroxyprogesterone Acetate Intravaginal Sponges [PDF]

, 2017
Medroxyprogesterone acetate is widely used in veterinary medicine as intravaginal dosage for the synchronization of breeding cycle in ewes and goats. The main goal of this study was to develop reverse-phase high-performance liquid chromatography method ...
Murad Abualhasan, Shorouq Wahdan, Nidal Batrawi   +2 more
core   +1 more source

Sonar findings of the uterus in patients on medroxyprogesterone acetate (Depo Provera) 150 mg injection

South African Family Practice, 2009
Background: Depo Provera (medroxyprogesterone acetate) 150 mg intramuscular injection every 12 weeks is one of the most common, effective, affordable and popular methods of contraception.
Louis A. de Wilde, Wilhelm J. Steinberg, Mariette Nel   +2 more
doaj   +1 more source

Development of a subcutaneous endometriosis rat model [PDF]

Acta Cirúrgica Brasileira, 2015
PURPOSE:To present a rat model of subcutaneous endometriosis for the study of pathophysiology and the effects of drugs.METHODS: Fifty three-month-old female Wistar rats (Rattus norvergicus) were distributed into one control group and four treatment ...
Francisco Edson Ximenes Gomes Pereira, Paulo Roberto Carvalho de Almeida, Bruno Hállan Meneses Dias, Paulo Roberto Leitão de Vasconcelos, Sérgio Botelho Guimarães, Francisco das Chagas Medeiros   +5 more
doaj   +1 more source

Efficacy and Safety of Elagolix Versus Dienogest for Treatment of Moderate‐to‐Severe Endometriosis Pain: A Phase III, Multicentric, Double‐Blind, Active‐Controlled, Non‐Inferiority Study

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To compare the efficacy, safety and tolerability of elagolix with dienogest in women with moderate‐to‐severe endometriosis‐associated pain. Design A multicentre, double‐blind, double‐dummy, randomised, parallel‐group, active‐controlled, non‐inferiority phase III study. Setting Nineteen clinical centres across India.
Sneha Bhoir, Jaldhara Patel, Tushar Palve, Mrinal Kanti Dash, Sweety Saigal, Gourisankar Kamilya, Shalini Srivastava, Kartikbhai Savalia, Tanusree Gupta, Deepa Choudhary, Manohar Rangaswamy, Vidya V Bhatt, Neena Gupta, Malathi Ponnuru, Parul Shah, Apurva Shetty, Shruti Saha, Reshma Quadros, Sucheta Pandit, Dipak Patil, Piyush Patel, Pravin Ghadge, Lalit Lakhwani, Suyog Mehta, Sadhana Joglekar   +24 more
wiley   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas, Olivia Carere, Lauren Clarfield, Michelle Jacobson   +3 more
wiley   +1 more source

Phase behavior of carbon dioxide + medroxyprogesterone acetate system at high pressures [PDF]

, 2013
In this study the phase equilibrium behavior of the binary system CO2 (1) + medroxyprogesterone acetate (2) was determined. The static synthetic method, using a variable-volume view cell, was employed to obtain the experimental data in the temperature ...
Zabaloy, Marcelo Santiago, Pinto, L. F., Cabral, V. F., Cardozo Filho, L., Araújo, P. H. H. de, Corazza, M. L., Rodriguez Reartes, Sabrina Belen, Madureira, E. H.   +7 more
core   +1 more source